These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28714596)

  • 21. Application of mesoscale simulation to explore the aggregate morphology of pH-sensitive nanoparticles used as the oral drug delivery carriers under different conditions.
    Wang Y; Chen BZ; Liu YJ; Wu ZM; Guo XD
    Colloids Surf B Biointerfaces; 2017 Mar; 151():280-286. PubMed ID: 28038414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-culture.
    Lai X; Agarwal M; Lvov YM; Pachpande C; Varahramyan K; Witzmann FA
    J Appl Toxicol; 2013 Nov; 33(11):1316-29. PubMed ID: 23606564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination.
    Vandamme K; Melkebeek V; Cox E; Deforce D; Lenoir J; Adriaens E; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2010 Feb; 74(2):202-8. PubMed ID: 19819332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity.
    Riela S; Massaro M; Colletti CG; Bommarito A; Giordano C; Milioto S; Noto R; Poma P; Lazzara G
    Int J Pharm; 2014 Nov; 475(1-2):613-23. PubMed ID: 25223492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery.
    Sgorla D; Lechanteur A; Almeida A; Sousa F; Melo E; Bunhak É; Mainardes R; Khalil N; Cavalcanti O; Sarmento B
    Expert Opin Drug Deliv; 2018 Mar; 15(3):213-222. PubMed ID: 29257904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs.
    Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y
    J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
    Sajeesh S; Sharma CP
    Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
    Nguyen MH; Yu H; Kiew TY; Hadinoto K
    Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
    Vakilinezhad MA; Amini A; Dara T; Alipour S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma-aminobutyric acid loaded halloysite nanotubes and in vitro-in vivo evaluation for brain delivery.
    Kırımlıoğlu GY; Yazan Y; Erol K; Çengelli Ünel Ç
    Int J Pharm; 2015 Nov; 495(2):816-26. PubMed ID: 26387616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems.
    Cerchiara T; Luppi B; Chidichimo G; Bigucci F; Zecchi V
    Eur J Pharm Biopharm; 2005 Oct; 61(3):195-200. PubMed ID: 16006107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioadhesive poly(methyl vinyl ether-co-maleic anhydride)-TPGS copolymer modified PLGA/lipid hybrid nanoparticles for improving intestinal absorption of cabazitaxel.
    Ren T; Zheng X; Bai R; Yang Y; Jian L
    Int J Pharm; 2022 Jan; 611():121301. PubMed ID: 34793933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of multifunctional PEG-graft-Halloysite Nanotubes for Controlled Drug Release, Tumor Cell Targeting, and Bio-imaging.
    Yamina AM; Fizir M; Itatahine A; He H; Dramou P
    Colloids Surf B Biointerfaces; 2018 Oct; 170():322-329. PubMed ID: 29936385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucoadhesive micro-composites: Chitosan coated halloysite nanotubes for sustained drug delivery.
    Sharif S; Abbas G; Hanif M; Bernkop-Schnürch A; Jalil A; Yaqoob M
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110527. PubMed ID: 31577976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.
    Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS
    Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride.
    Varshosaz J; Minaiyan M; Dayyani L
    Eur J Pharm Sci; 2018 Jan; 112():195-206. PubMed ID: 29196024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.